data; tool available upon request) was used to identify SNPs between the cluster isolates and 10 additional publically available C.
Acute- and convalescent-phase serum samples were assayed for antibodies to C.
Because coccidioidomycosis skin test reagents are currently unavailable, testing for antibodies to coccidioidomycosis was performed to assess prior immunity to C.
Acute-phase serum specimens from 9 of 10 persons who met the clinical case definition contained IgM antibodies to C.
by watering down the soil and wearing National Institute for Occupational Safety and Health [NIOSH]-approved N95 respirators) at Swelter Shelter to reduce their risk for C.
First, the serologic survey failed to find recent serologic evidence of C.
The amorphous mass was formed as the exopolysaccharide matrix material was condensed by dehydration, but the 4- to 6-[micro]m spherical profiles of the C.
and Cryptococcus neoformans have been shown to produce biofilms on catheters (4,5); our case demonstrates that C.
We studied five of the 10 loci originally used for each C.
The laboratory criteria include a positive culture, positive histopathologic results, molecular evidence of C.
The discovery of recombination in clinical isolates of C.
The laboratories were also provided with guidelines for safe transport of C.